Global Dosimeters Market, by Product Type (Active Dosimeters and Passive Dosimeters), by Modality (Portable Dosimeters (Wearable (Collar Level, Chest Level, Waist Level, Wrist Level, and Finger Level (i.e. Ring Dosimeters)), and Non-wearable), and Bench-top Dosimeters), by End User (Hospitals, Ambulatory Care Centers, Research Institutes, and Healthcare Companies), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 847.0 Mn in 2017, and is projected to exhibit a CAGR of 4.2% over the forecast period (2018 – 2026).
Increasing adoption of radiation emitting diagnostic tools and therapies is expected to drive the dosimeters market growth in near future. Increasing adaption of diagnosis tools such as CT scan and MRI by hospitals and ambulatory care centers is expected to increase the demand for the dosimeters for the professionals working with these tools. Hence, increasing installments of these devices is expected to increase demand for dosimeters and drive the global dosimeters market growth in near future. For instance, According to the data published by Organization for Economic Co-operation and Development (OECD), in France the total unit of Magnetic Resonance Imaging (MRI) in hospital and ambulatory care centers in 2015, were around 12.6 per 1,000,000 inhabitants increasing from 7.0 per 1,000,000 population in 2010. Furthermore, launches of novel dosimeters is also expected to fuel the dosimeters market growth in near future. For instance, in February 2018, Mirion Technologies, Inc. launched new instadose+ dosimetry system. This new dosimeter saves the time by eliminating the badge collection process and long time to measure dose of badge in laboratory. It operates on Bluetooth Low Energy (BLE) Technology to transmit dose data that can be seen on smart devices and PCs. This device also alerts users by sending e-mail if a dose exceeds a user-specified level.
Browse 29 Market Data Tables and 37 Figures spread through 190 Pages and in-depth TOC on Dosimeters Market by Product Type (Active Dosimeters and Passive Dosimeters), by Modality (Portable Dosimeters (Wearable (Collar Level, Chest Level, Waist Level, Wrist Level, and Finger Level (i.e. Ring Dosimeters)), and Non-wearable), and Bench-top Dosimeters), by End User (Hospitals, Ambulatory Care Centers, Research Institutes, and Healthcare Companies), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026.
To know the latest trends and insights prevalent in the Dosimeters Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/dosimeters-market-1918
Increasing adoption of radiotherapy and nuclear medicine treatment for diagnosis of cancer is expected to increase the demand for the dosimeters for medical professionals delivering these therapies and also among healthcare manufacturers engaged in developing these therapies. Hence, increasing prevalence of cancer is expected to propel demand for these therapies, which in turn is expected to drive growth of the dosimeters market in near future. For instance, According to Cancer Research UK, around 357,000 new cases of cancer were diagnosed in the U.K. in 2014, around 980 cases were diagnosed every day in the country. The data also suggests that every two minutes, a person in the U.K. is diagnosed with some kind of cancer, out of which almost half of the cancer cases are detected in the late stages Key Takeaways of the Dosimeters Market:
- The global dosimeters market is expected to exhibit a CAGR of 4.2% over the forecast period (2018 – 2026), owing to frequent product launches, approval, and robust pipeline of novel biopharmaceutical products
- North America held the dominant position in the global dosimeters market and is expected to retain its dominance over the forecast period (2018 – 2026), owing to presence of major market players and product development and innovations in the region. For instance, Thermo Fisher Scientific, Mirion Technologies, Inc., PRS Dosimetry, Radiation Detection Company, and Landauer, Inc., are U.S.-based key players who provide wide range of dosimeters in the region.
- Asia Pacific is expected to witness significant growth over the forecast period due to increasing launches of novel dosimeters in economies such as Japan and China, which is expected to drive growth of the market in Asia Pacific region. For instance, in 2013, Unfors RaySafe, Inc., a subsidiary of Fluke Biomedical LLC, launched novel RaySafe i2 active dosimeter in Japan.
- Major players operating in the dosimeters market include Thermo Fisher Scientific Inc., PRS Dosimetry, Mirion Technologies Inc., Landauer Inc., Polimaster Ltd., Radiation Detection Company Inc., Sierra Radiation Dosimetry Services Inc., Tracerco Limited, Unfors RaySafe AB, and PTW Frieburg GmbH
